FWBI NASDAQ
First Wave BioPharma, Inc.
1W: -15.2%
1M: -26.9%
3M: -56.3%
1Y: -94.1%
3Y: -100.0%
5Y: -100.0%
$2.96
Last traded 2024-06-14 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+100.0% ▲
Operating Income
-$16M
+0.9% ▲
Net Income
-$18M
-14.3% ▼
EPS (Diluted)
$-5.33
+88.6% ▲
EBITDA
-$16M
+0.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $571K | $537K | $106K | $29K | $0 |
| Gross Profit | -$571K | -$537K | -$106K | -$29K | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $19M | $38M | $691K | $5M | $904K |
| SG&A Expenses | $7M | $18M | $12M | $11M | $15M |
| Operating Expenses | $26M | $57M | $13M | $16M | $16M |
| Operating Income | -$26M | -$59M | -$13M | -$16M | -$16M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $6M | $11K | $16K | $0 | $875 |
| Income Before Tax | -$33M | -$59M | -$15M | -$16M | -$18M |
| Tax Expense | $6M | $540K | $2M | $0 | $0 |
| Net Income | -$39M | -$59M | -$17M | -$16M | -$18M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-57194.08 | $-27799.23 | $-461.72 | $-46.96 | $-5.33 |
| EBITDA | -$26M | -$56M | -$13M | -$16M | -$16M |
| Shares Outstanding | 677 | 2125 | 35912 | 336342 | 3M |